{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:38:49Z","timestamp":1767904729449,"version":"3.49.0"},"reference-count":122,"publisher":"Harborside Press, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Breast cancer risk stratification models identify individuals at increased risk, allowing earlier screening than for those at average risk and potentially improving health outcomes. Due to the increasing rates of breast cancer in individuals aged &lt;40 years, especially among Black females, the American College of Radiology now recommends all females initiate breast cancer risk assessment by age 25 years. Several breast cancer risk prediction models are readily available, including the Gail Model, Breast Cancer Surveillance Consortium Risk Calculator, BOADICEA, and Tyrer-Cuzick Model. However, because these models were primarily developed using data from White women of European ancestry, they may underestimate risk in Black women. Indeed, current evidence suggests that these models underpredict breast cancer risk among Black women, particularly those of African ancestry. Although cancer risk prediction models typically incorporate personal characteristics, family history of cancer, and hormonal and lifestyle factors, inherited breast cancer genes can also increase risk for breast cancer. Beyond monogenic inherited breast cancer genes that increase breast cancer risk, emerging data suggest that single nucleotide polymorphisms identified through genome-wide association studies (GWAS) may be used to generate polygenic risk scores, which may further refine breast cancer risk. However, GWAS data are also primarily gathered from European ancestry females, further reducing the ability to accurately stratify breast cancer risk in non-European ancestry populations. Current data highlight the importance of ensuring representation from all populations in developing cancer risk prediction models, conducting genomics research, and designing effective implementation strategies to enhance the use of these models in routine clinical care. Although new analytic methods and models are being developed to improve breast cancer risk stratification across populations, it remains critical to assess the utility and calibration of existing and new models to ensure applicability across non-European ancestry populations.<\/jats:p>","DOI":"10.6004\/jnccn.2025.7079","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:11:47Z","timestamp":1765548707000},"source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer Risk Stratification in Black Women: Current Status and Potential Solutions to Improve Accuracy"],"prefix":"10.6004","volume":"24","author":[{"given":"Sonya","family":"Reid","sequence":"first","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center, Nashville, TN"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Spalluto","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center, Nashville, TN"},{"name":"Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN"},{"name":"Geriatric Research and Education Clinical Center (GRECC) and VETWISE-LHS Center of Innovation, VA Tennessee Valley Healthcare System, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuya","family":"Pal","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center, Nashville, TN"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","reference":[{"key":"B1","series-title":"CA Cancer J Clin","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow D","year":"2007","unstructured":"Saslow D, Boetes C, Burke W,  American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75\u201389."},{"key":"B2","series-title":"Ann Surg Oncol","first-page":"6419","article-title":"Black women are less likely to be classified as high-risk for breast cancer using the Tyrer-Cuzick 8 model","volume":"29","author":"Porterhouse MD","year":"2022","unstructured":"Porterhouse MD, Paul S, Lieberenz JL,  Black women are less likely to be classified as high-risk for breast cancer using the Tyrer-Cuzick 8 model. Ann Surg Oncol 2022;29:6419\u20136425."},{"key":"B3","series-title":"J Natl Cancer Inst","first-page":"785","article-title":"Comparing 5-year and lifetime risks of breast cancer using the prospective family study cohort","volume":"113","author":"MacInnis RJ","year":"2021","unstructured":"MacInnis RJ, Knight JA, Chung WK,  Comparing 5-year and lifetime risks of breast cancer using the prospective family study cohort. J Natl Cancer Inst 2021;113:785\u2013791."},{"key":"B4","series-title":"Appl Radiol","first-page":"8","article-title":"Next top model: an overview of breast cancer risk assessment models","volume":"53","author":"Agrawal P","year":"2024","unstructured":"Agrawal P, Audet CM, Ernst L,  Next top model: an overview of breast cancer risk assessment models. Appl Radiol 2024;53:8\u201315."},{"key":"B5","series-title":"Breast","first-page":"71","article-title":"Polygenic risk scores and breast cancer risk prediction","volume":"67","author":"Roberts E","year":"2023","unstructured":"Roberts E, Howell S, Evans DG. Polygenic risk scores and breast cancer risk prediction. Breast 2023;67:71\u201377."},{"key":"B6","series-title":"Nat Genet","first-page":"584","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin AR","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y,  Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet 2019;51:584\u2013591."},{"key":"B7","series-title":"CA Cancer J Clin","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto AN","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA,  Breast cancer statistics 2024. CA Cancer J Clin 2024;74:477\u2013495."},{"key":"B8","series-title":"J Natl Cancer Inst","first-page":"1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail MH","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP,  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879\u20131886."},{"key":"B9","series-title":"Ann Intern Med","first-page":"337","article-title":"Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model","volume":"148","author":"Tice JA","year":"2008","unstructured":"Tice JA, Cummings SR, Smith-Bindman R,  Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008;148:337\u2013347."},{"key":"B10","series-title":"Genet Med","first-page":"1708","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee A","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN,  BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 2019;21:1708\u20131718."},{"key":"B11","series-title":"Stat Med","first-page":"1111","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer J","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23:1111\u20131130."},{"key":"B12","series-title":"Breast J","first-page":"332","article-title":"Diagnostic accuracy of the Gail model in the Black Women\u2019s Health Study","volume":"13","author":"Adams-Campbell LL","year":"2007","unstructured":"Adams-Campbell LL, Makambi KH, Palmer JR, Rosenberg L. Diagnostic accuracy of the Gail model in the Black Women\u2019s Health Study. Breast J 2007;13:332\u2013336."},{"key":"B13","series-title":"Clin Trials","first-page":"280","article-title":"National Surgical Adjuvant Breast and Bowel Project Study of tamoxifen and raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities","volume":"10","author":"McCaskill-Stevens W","year":"2013","unstructured":"McCaskill-Stevens W, Wilson JW, Cook ED,  National Surgical Adjuvant Breast and Bowel Project Study of tamoxifen and raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities. Clin Trials 2013;10:280\u2013291."},{"key":"B14","series-title":"J Natl Cancer Inst","first-page":"1782","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women","volume":"99","author":"Gail MH","year":"2007","unstructured":"Gail MH, Costantino JP, Pee D,  Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007;99:1782\u20131792."},{"key":"B15","series-title":"J Clin Oncol","first-page":"3137","article-title":"Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer","volume":"33","author":"Tice JA","year":"2015","unstructured":"Tice JA, Miglioretti DL, Li CS,  Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 2015;33:3137\u20133143."},{"key":"B16","series-title":"J Med Genet","first-page":"1196","article-title":"Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study","volume":"59","author":"Yang X","year":"2022","unstructured":"Yang X, Eriksson M, Czene K,  Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. J Med Genet 2022;59:1196\u20131205."},{"key":"B17","article-title":"Can I use the CanRisk Tool to estimate risks for populations outside Europe? CanRisk Knowledgebase","unstructured":"Carver T. Can I use the CanRisk Tool to estimate risks for populations outside Europe? CanRisk Knowledgebase. Accessed October 24, 2025. Available at: https:\/\/canrisk.atlassian.net\/wiki\/spaces\/FAQS\/pages\/28180481"},{"key":"B18","series-title":"J Clin Oncol","first-page":"3866","article-title":"A validated risk prediction model for breast cancer in US Black women","volume":"39","author":"Palmer JR","year":"2021","unstructured":"Palmer JR, Zirpoli G, Bertrand KA,  A validated risk prediction model for breast cancer in US Black women. J Clin Oncol 2021;39:3866\u20133877."},{"key":"B19","series-title":"J Am Coll Radiol","first-page":"902","article-title":"Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR","volume":"20","author":"Monticciolo DL","year":"2023","unstructured":"Monticciolo DL, Newell MS, Moy L,  Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR. J Am Coll Radiol 2023;20:902\u2013914."},{"key":"B20","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2.2024","unstructured":"Daly MB, Pal T, Maxwell KN, et al. NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2.2024. Accessed June 14, 2024. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B21","series-title":"N Engl J Med","first-page":"428","article-title":"Breast cancer risk genes - association analysis in more than 113,000 women","volume":"384","author":"Dorling L","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J,  Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med 2021;384:428\u2013439."},{"key":"B22","series-title":"N Engl J Med","first-page":"440","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu C","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R,  A population-based study of genes previously implicated in breast cancer. N Engl J Med 2021;384:440\u2013451."},{"key":"B23","series-title":"Curr Treat Options Oncol","first-page":"39.","article-title":"Health care disparities in hereditary ovarian cancer: are we reaching the underserved population?","volume":"17","author":"Randall TC","year":"2016","unstructured":"Randall TC, Armstrong K. Health care disparities in hereditary ovarian cancer: are we reaching the underserved population? Curr Treat Options Oncol 2016;17:39."},{"key":"B24","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"162","article-title":"Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups","volume":"15","author":"Kaplan CP","year":"2006","unstructured":"Kaplan CP, Haas JS, Perez-Stable EJ,  Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev 2006;15:162\u2013166."},{"key":"B25","series-title":"Gynecol Oncol","first-page":"383","article-title":"Awareness and acceptability of population-based screening for pathogenic BRCA variants: do race and ethnicity matter?","volume":"154","author":"Rubinsak LA","year":"2019","unstructured":"Rubinsak LA, Kleinman A, Quillin J,  Awareness and acceptability of population-based screening for pathogenic BRCA variants: do race and ethnicity matter? Gynecol Oncol 2019;154:383\u2013387."},{"key":"B26","series-title":"J Clin Oncol","first-page":"1584","article-title":"Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer","volume":"33","author":"Jagsi R","year":"2015","unstructured":"Jagsi R, Griffith KA, Kurian AW,  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J Clin Oncol 2015;33:1584\u20131591."},{"key":"B27","series-title":"J Clin Oncol","first-page":"2610","article-title":"Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer","volume":"34","author":"McCarthy AM","year":"2016","unstructured":"McCarthy AM, Bristol M, Domchek SM,  Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer. J Clin Oncol 2016;34:2610\u20132618."},{"key":"B28","series-title":"J Clin Oncol","first-page":"4020","article-title":"Genetic counseling and testing in African American patients with breast cancer: a nationwide survey of US breast oncologists","volume":"39","author":"Ademuyiwa FO","year":"2021","unstructured":"Ademuyiwa FO, Salyer P, Tao Y,  Genetic counseling and testing in African American patients with breast cancer: a nationwide survey of US breast oncologists. J Clin Oncol 2021;39:4020\u20134028."},{"key":"B29","series-title":"JAMA","first-page":"43","article-title":"Germline genetic testing after cancer diagnosis","volume":"330","author":"Kurian AW","year":"2023","unstructured":"Kurian AW, Abrahamse P, Furgal A,  Germline genetic testing after cancer diagnosis. JAMA 2023;330:43\u201351."},{"key":"B30","series-title":"J Cancer Educ","first-page":"344","article-title":"What Black women know and want to know about counseling and testing for BRCA1\/2","volume":"30","author":"Adams I","year":"2015","unstructured":"Adams I, Christopher J, Williams KP, Sheppard VB. What Black women know and want to know about counseling and testing for BRCA1\/2. J Cancer Educ 2015;30:344\u2013352."},{"key":"B31","series-title":"J Genet Couns","first-page":"311","article-title":"African American women\u2019s limited knowledge and experiences with genetic counseling for hereditary breast cancer","volume":"23","author":"Sheppard VB","year":"2014","unstructured":"Sheppard VB, Graves KD, Christopher J,  African American women\u2019s limited knowledge and experiences with genetic counseling for hereditary breast cancer. J Genet Couns 2014;23:311\u2013322."},{"key":"B32","series-title":"Ethn Dis","first-page":"267","article-title":"Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study","volume":"22","author":"Glenn BA","year":"2012","unstructured":"Glenn BA, Chawla N, Bastani R. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis 2012;22:267\u2013273."},{"key":"B33","series-title":"Ann Surg Oncol","first-page":"5197","article-title":"Racial disparities in breast cancer genetic testing may be mitigated by counseling","volume":"31","author":"Siegel JB","year":"2024","unstructured":"Siegel JB, Bertolino M, Mukherjee R,  Racial disparities in breast cancer genetic testing may be mitigated by counseling. Ann Surg Oncol 2024;31:5197\u20135204."},{"key":"B34","series-title":"J Natl Cancer Inst","first-page":"1213","article-title":"Contribution of germline predisposition gene mutations to breast cancer risk in African American women","volume":"112","author":"Palmer JR","year":"2020","unstructured":"Palmer JR, Polley EC, Hu C,  Contribution of germline predisposition gene mutations to breast cancer risk in African American women. J Natl Cancer Inst 2020;112:1213\u20131221."},{"key":"B35","series-title":"Genet Med","first-page":"1468","article-title":"Evaluating breast cancer predisposition genes in women of African ancestry","volume":"24","author":"D\u00edaz-Zabala H","year":"2022","unstructured":"D\u00edaz-Zabala H, Guo X, Ping J,  Evaluating breast cancer predisposition genes in women of African ancestry. Genet Med 2022;24:1468\u20131475."},{"key":"B36","series-title":"Cancer","first-page":"4173","article-title":"A high frequency of BRCA mutations in young black women with breast cancer residing in Florida","volume":"121","author":"Pal T","year":"2015","unstructured":"Pal T, Bonner D, Cragun D,  A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer 2015;121:4173\u20134180."},{"key":"B37","series-title":"Clin Breast Cancer","first-page":"e220","article-title":"Health care disparities and demand for expanding hereditary breast cancer screening guidelines in African Americans","volume":"21","author":"Ciuro J","year":"2021","unstructured":"Ciuro J, Beyer A, Fritzler J,  Health care disparities and demand for expanding hereditary breast cancer screening guidelines in African Americans. Clin Breast Cancer 2021;21:e220\u2013227."},{"key":"B38","series-title":"Breast Cancer Res Treat","first-page":"591","article-title":"A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas","volume":"125","author":"Donenberg T","year":"2011","unstructured":"Donenberg T, Lunn J, Curling D,  A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat 2011;125:591\u2013596."},{"key":"B39","series-title":"Breast Cancer Res Treat","first-page":"131","article-title":"A survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago","volume":"159","author":"Donenberg T","year":"2016","unstructured":"Donenberg T, Ahmed H, Royer R,  A survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Breast Cancer Res Treat 2016;159:131\u2013138."},{"key":"B40","series-title":"J Clin Oncol","first-page":"2820","article-title":"Inherited breast cancer in Nigerian women","volume":"36","author":"Zheng Y","year":"2018","unstructured":"Zheng Y, Walsh T, Gulsuner S,  Inherited breast cancer in Nigerian women. J Clin Oncol 2018;36:2820\u20132825."},{"key":"B41","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"359","article-title":"Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon","volume":"29","author":"Adedokun B","year":"2020","unstructured":"Adedokun B, Zheng Y, Ndom P,  Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon. Cancer Epidemiol Biomarkers Prev 2020;29:359\u2013367."},{"key":"B42","series-title":"JAMA Oncol","first-page":"1045","article-title":"Comparison of the prevalence of pathogenic variants in cancer susceptibility genes in Black women and Non-Hispanic White women with breast cancer in the United States","volume":"7","author":"Domchek SM","year":"2021","unstructured":"Domchek SM, Yao S, Chen F,  Comparison of the prevalence of pathogenic variants in cancer susceptibility genes in Black women and Non-Hispanic White women with breast cancer in the United States. JAMA Oncol 2021;7:1045\u20131050."},{"key":"B43","series-title":"Genet Med","first-page":"601","article-title":"Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank","volume":"24","author":"Wang L","year":"2022","unstructured":"Wang L, Desai H, Verma SS,  Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank. Genet Med 2022;24:601\u2013609."},{"key":"B44","series-title":"Genet Med","first-page":"549","article-title":"Diversity in cancer genomics research is a matter of equity and scientific discovery","volume":"24","author":"Pal T","year":"2022","unstructured":"Pal T. Diversity in cancer genomics research is a matter of equity and scientific discovery. Genet Med 2022;24:549\u2013551."},{"key":"B45","series-title":"JCO Precis Oncol","first-page":"e2200084.","article-title":"Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition","volume":"6","author":"Hughes E","year":"2022","unstructured":"Hughes E, Wagner S, Pruss D,  Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition. JCO Precis Oncol 2022;6:e2200084."},{"key":"B46","series-title":"Genet Med","first-page":"101128.","article-title":"Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors","volume":"26","author":"Mabey B","year":"2024","unstructured":"Mabey B, Hughes E, Kucera M,  Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors. Genet Med 2024;26:101128."},{"key":"B47","series-title":"PLoS Med","first-page":"e1002644.","article-title":"Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: a nested case\u2013control study","volume":"15","author":"Zhang X","year":"2018","unstructured":"Zhang X, Rice M, Tworoger SS,  Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: a nested case\u2013control study. PLoS Med 2018;15:e1002644."},{"key":"B48","series-title":"J Natl Cancer Inst","article-title":"Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial","volume":"109","author":"Shieh Y","year":"2017","unstructured":"Shieh Y, Eklund M, Madlensky L,  Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Natl Cancer Inst 2017;109."},{"key":"B49","series-title":"Breast Cancer Res","first-page":"2.","article-title":"Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women","volume":"26","author":"Zirpoli GR","year":"2024","unstructured":"Zirpoli GR, Pfeiffer RM, Bertrand KA,  Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Res 2024;26:2."},{"key":"B50","series-title":"J Clin Oncol","first-page":"2564","article-title":"Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score","volume":"39","author":"Gao C","year":"2021","unstructured":"Gao C, Polley EC, Hart SN,  Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score. J Clin Oncol 2021;39:2564\u20132573."},{"key":"B51","series-title":"JAMA Netw Open","first-page":"e208501.","article-title":"Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes","volume":"3","author":"Gallagher S","year":"2020","unstructured":"Gallagher S, Hughes E, Wagner S,  Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes. JAMA Netw Open 2020;3:e208501."},{"key":"B52","series-title":"JAMA Oncol","first-page":"1066","article-title":"Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer","volume":"4","author":"Kurian AW","year":"2018","unstructured":"Kurian AW, Ward KC, Hamilton AS,  Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer. JAMA Oncol 2018;4:1066\u20131072."},{"key":"B53","series-title":"J Am Coll Radiol","first-page":"408","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo DL","year":"2018","unstructured":"Monticciolo DL, Newell MS, Moy L,  Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 2018;15:408\u2013414."},{"key":"B54","article-title":"Position statement on screening mammography","unstructured":"The American Society of Breast Surgeons. Position statement on screening mammography. Accessed May 13, 2021. Available at: https:\/\/www.breastsurgeons.org\/docs\/statements\/Position-Statement-on-Screening-Mammography.pdf"},{"key":"B55","series-title":"J Health Care Poor Underserved","first-page":"34","article-title":"Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research","volume":"23","author":"Anderson EE","year":"2012","unstructured":"Anderson EE, Hoskins K. Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research. J Health Care Poor Underserved 2012;23(Suppl 4): 34\u201346."},{"key":"B56","series-title":"J R Soc Med","first-page":"510","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris ZS","year":"2011","unstructured":"Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011;104:510\u2013520."},{"key":"B57","series-title":"JAMA","first-page":"403","article-title":"Practice-based research\u2013\u201cBlue Highways\u201d on the NIH roadmap","volume":"297","author":"Westfall JM","year":"2007","unstructured":"Westfall JM, Mold J, Fagnan L. Practice-based research\u2013\u201cBlue Highways\u201d on the NIH roadmap. JAMA 2007;297:403\u2013406."},{"key":"B58","series-title":"Maturitas","first-page":"107949.","article-title":"Racial disparities in breast cancer risk factors and risk management","volume":"184","author":"Pederson HJ","year":"2024","unstructured":"Pederson HJ, Al-Hilli Z, Kurian AW. Racial disparities in breast cancer risk factors and risk management. Maturitas 2024;184:107949."},{"key":"B59","series-title":"J Am Coll Radiol","first-page":"314","article-title":"Black women\u2019s perspectives on breast cancer risk assessment","volume":"20","author":"Spalluto LB","year":"2023","unstructured":"Spalluto LB, Bonnet K, Sonubi C,  Black women\u2019s perspectives on breast cancer risk assessment. J Am Coll Radiol 2023;20:314\u2013323."},{"key":"B60","series-title":"J Am Coll Radiol","first-page":"342","article-title":"Barriers to implementation of breast cancer risk assessment: the health care team perspective","volume":"20","author":"Spalluto LB","year":"2023","unstructured":"Spalluto LB, Bonnet K, Sonubi C,  Barriers to implementation of breast cancer risk assessment: the health care team perspective. J Am Coll Radiol 2023;20:342\u2013351."},{"key":"B61","series-title":"J Am Coll Radiol","first-page":"547","article-title":"Racial and ethnic disparities in radiology: a call to action","volume":"16","author":"Betancourt JR","year":"2019","unstructured":"Betancourt JR, Tan-McGrory A, Flores E, L\u00f3pez D. Racial and ethnic disparities in radiology: a call to action. J Am Coll Radiol 2019;16:547\u2013553."},{"key":"B1","series-title":"CA Cancer J Clin","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow D","year":"2007","unstructured":"Saslow D, Boetes C, Burke W,  American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75\u201389."},{"key":"B2","series-title":"Ann Surg Oncol","first-page":"6419","article-title":"Black women are less likely to be classified as high-risk for breast cancer using the Tyrer-Cuzick 8 model","volume":"29","author":"Porterhouse MD","year":"2022","unstructured":"Porterhouse MD, Paul S, Lieberenz JL,  Black women are less likely to be classified as high-risk for breast cancer using the Tyrer-Cuzick 8 model. Ann Surg Oncol 2022;29:6419\u20136425."},{"key":"B3","series-title":"J Natl Cancer Inst","first-page":"785","article-title":"Comparing 5-year and lifetime risks of breast cancer using the prospective family study cohort","volume":"113","author":"MacInnis RJ","year":"2021","unstructured":"MacInnis RJ, Knight JA, Chung WK,  Comparing 5-year and lifetime risks of breast cancer using the prospective family study cohort. J Natl Cancer Inst 2021;113:785\u2013791."},{"key":"B4","series-title":"Appl Radiol","first-page":"8","article-title":"Next top model: an overview of breast cancer risk assessment models","volume":"53","author":"Agrawal P","year":"2024","unstructured":"Agrawal P, Audet CM, Ernst L,  Next top model: an overview of breast cancer risk assessment models. Appl Radiol 2024;53:8\u201315."},{"key":"B5","series-title":"Breast","first-page":"71","article-title":"Polygenic risk scores and breast cancer risk prediction","volume":"67","author":"Roberts E","year":"2023","unstructured":"Roberts E, Howell S, Evans DG. Polygenic risk scores and breast cancer risk prediction. Breast 2023;67:71\u201377."},{"key":"B6","series-title":"Nat Genet","first-page":"584","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin AR","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y,  Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet 2019;51:584\u2013591."},{"key":"B7","series-title":"CA Cancer J Clin","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto AN","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA,  Breast cancer statistics 2024. CA Cancer J Clin 2024;74:477\u2013495."},{"key":"B8","series-title":"J Natl Cancer Inst","first-page":"1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail MH","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP,  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879\u20131886."},{"key":"B9","series-title":"Ann Intern Med","first-page":"337","article-title":"Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model","volume":"148","author":"Tice JA","year":"2008","unstructured":"Tice JA, Cummings SR, Smith-Bindman R,  Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008;148:337\u2013347."},{"key":"B10","series-title":"Genet Med","first-page":"1708","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee A","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN,  BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 2019;21:1708\u20131718."},{"key":"B11","series-title":"Stat Med","first-page":"1111","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer J","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23:1111\u20131130."},{"key":"B12","series-title":"Breast J","first-page":"332","article-title":"Diagnostic accuracy of the Gail model in the Black Women\u2019s Health Study","volume":"13","author":"Adams-Campbell LL","year":"2007","unstructured":"Adams-Campbell LL, Makambi KH, Palmer JR, Rosenberg L. Diagnostic accuracy of the Gail model in the Black Women\u2019s Health Study. Breast J 2007;13:332\u2013336."},{"key":"B13","series-title":"Clin Trials","first-page":"280","article-title":"National Surgical Adjuvant Breast and Bowel Project Study of tamoxifen and raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities","volume":"10","author":"McCaskill-Stevens W","year":"2013","unstructured":"McCaskill-Stevens W, Wilson JW, Cook ED,  National Surgical Adjuvant Breast and Bowel Project Study of tamoxifen and raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities. Clin Trials 2013;10:280\u2013291."},{"key":"B14","series-title":"J Natl Cancer Inst","first-page":"1782","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women","volume":"99","author":"Gail MH","year":"2007","unstructured":"Gail MH, Costantino JP, Pee D,  Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007;99:1782\u20131792."},{"key":"B15","series-title":"J Clin Oncol","first-page":"3137","article-title":"Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer","volume":"33","author":"Tice JA","year":"2015","unstructured":"Tice JA, Miglioretti DL, Li CS,  Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 2015;33:3137\u20133143."},{"key":"B16","series-title":"J Med Genet","first-page":"1196","article-title":"Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study","volume":"59","author":"Yang X","year":"2022","unstructured":"Yang X, Eriksson M, Czene K,  Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. J Med Genet 2022;59:1196\u20131205."},{"key":"B17","article-title":"Can I use the CanRisk Tool to estimate risks for populations outside Europe? CanRisk Knowledgebase","unstructured":"Carver T. Can I use the CanRisk Tool to estimate risks for populations outside Europe? CanRisk Knowledgebase. Accessed October 24, 2025. Available at: https:\/\/canrisk.atlassian.net\/wiki\/spaces\/FAQS\/pages\/28180481"},{"key":"B18","series-title":"J Clin Oncol","first-page":"3866","article-title":"A validated risk prediction model for breast cancer in US Black women","volume":"39","author":"Palmer JR","year":"2021","unstructured":"Palmer JR, Zirpoli G, Bertrand KA,  A validated risk prediction model for breast cancer in US Black women. J Clin Oncol 2021;39:3866\u20133877."},{"key":"B19","series-title":"J Am Coll Radiol","first-page":"902","article-title":"Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR","volume":"20","author":"Monticciolo DL","year":"2023","unstructured":"Monticciolo DL, Newell MS, Moy L,  Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR. J Am Coll Radiol 2023;20:902\u2013914."},{"key":"B20","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2.2024","unstructured":"Daly MB, Pal T, Maxwell KN, et al. NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2.2024. Accessed June 14, 2024. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B21","series-title":"N Engl J Med","first-page":"428","article-title":"Breast cancer risk genes - association analysis in more than 113,000 women","volume":"384","author":"Dorling L","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J,  Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med 2021;384:428\u2013439."},{"key":"B22","series-title":"N Engl J Med","first-page":"440","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu C","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R,  A population-based study of genes previously implicated in breast cancer. N Engl J Med 2021;384:440\u2013451."},{"key":"B23","series-title":"Curr Treat Options Oncol","first-page":"39.","article-title":"Health care disparities in hereditary ovarian cancer: are we reaching the underserved population?","volume":"17","author":"Randall TC","year":"2016","unstructured":"Randall TC, Armstrong K. Health care disparities in hereditary ovarian cancer: are we reaching the underserved population? Curr Treat Options Oncol 2016;17:39."},{"key":"B24","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"162","article-title":"Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups","volume":"15","author":"Kaplan CP","year":"2006","unstructured":"Kaplan CP, Haas JS, Perez-Stable EJ,  Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev 2006;15:162\u2013166."},{"key":"B25","series-title":"Gynecol Oncol","first-page":"383","article-title":"Awareness and acceptability of population-based screening for pathogenic BRCA variants: do race and ethnicity matter?","volume":"154","author":"Rubinsak LA","year":"2019","unstructured":"Rubinsak LA, Kleinman A, Quillin J,  Awareness and acceptability of population-based screening for pathogenic BRCA variants: do race and ethnicity matter? Gynecol Oncol 2019;154:383\u2013387."},{"key":"B26","series-title":"J Clin Oncol","first-page":"1584","article-title":"Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer","volume":"33","author":"Jagsi R","year":"2015","unstructured":"Jagsi R, Griffith KA, Kurian AW,  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J Clin Oncol 2015;33:1584\u20131591."},{"key":"B27","series-title":"J Clin Oncol","first-page":"2610","article-title":"Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer","volume":"34","author":"McCarthy AM","year":"2016","unstructured":"McCarthy AM, Bristol M, Domchek SM,  Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer. J Clin Oncol 2016;34:2610\u20132618."},{"key":"B28","series-title":"J Clin Oncol","first-page":"4020","article-title":"Genetic counseling and testing in African American patients with breast cancer: a nationwide survey of US breast oncologists","volume":"39","author":"Ademuyiwa FO","year":"2021","unstructured":"Ademuyiwa FO, Salyer P, Tao Y,  Genetic counseling and testing in African American patients with breast cancer: a nationwide survey of US breast oncologists. J Clin Oncol 2021;39:4020\u20134028."},{"key":"B29","series-title":"JAMA","first-page":"43","article-title":"Germline genetic testing after cancer diagnosis","volume":"330","author":"Kurian AW","year":"2023","unstructured":"Kurian AW, Abrahamse P, Furgal A,  Germline genetic testing after cancer diagnosis. JAMA 2023;330:43\u201351."},{"key":"B30","series-title":"J Cancer Educ","first-page":"344","article-title":"What Black women know and want to know about counseling and testing for BRCA1\/2","volume":"30","author":"Adams I","year":"2015","unstructured":"Adams I, Christopher J, Williams KP, Sheppard VB. What Black women know and want to know about counseling and testing for BRCA1\/2. J Cancer Educ 2015;30:344\u2013352."},{"key":"B31","series-title":"J Genet Couns","first-page":"311","article-title":"African American women\u2019s limited knowledge and experiences with genetic counseling for hereditary breast cancer","volume":"23","author":"Sheppard VB","year":"2014","unstructured":"Sheppard VB, Graves KD, Christopher J,  African American women\u2019s limited knowledge and experiences with genetic counseling for hereditary breast cancer. J Genet Couns 2014;23:311\u2013322."},{"key":"B32","series-title":"Ethn Dis","first-page":"267","article-title":"Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study","volume":"22","author":"Glenn BA","year":"2012","unstructured":"Glenn BA, Chawla N, Bastani R. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis 2012;22:267\u2013273."},{"key":"B33","series-title":"Ann Surg Oncol","first-page":"5197","article-title":"Racial disparities in breast cancer genetic testing may be mitigated by counseling","volume":"31","author":"Siegel JB","year":"2024","unstructured":"Siegel JB, Bertolino M, Mukherjee R,  Racial disparities in breast cancer genetic testing may be mitigated by counseling. Ann Surg Oncol 2024;31:5197\u20135204."},{"key":"B34","series-title":"J Natl Cancer Inst","first-page":"1213","article-title":"Contribution of germline predisposition gene mutations to breast cancer risk in African American women","volume":"112","author":"Palmer JR","year":"2020","unstructured":"Palmer JR, Polley EC, Hu C,  Contribution of germline predisposition gene mutations to breast cancer risk in African American women. J Natl Cancer Inst 2020;112:1213\u20131221."},{"key":"B35","series-title":"Genet Med","first-page":"1468","article-title":"Evaluating breast cancer predisposition genes in women of African ancestry","volume":"24","author":"D\u00edaz-Zabala H","year":"2022","unstructured":"D\u00edaz-Zabala H, Guo X, Ping J,  Evaluating breast cancer predisposition genes in women of African ancestry. Genet Med 2022;24:1468\u20131475."},{"key":"B36","series-title":"Cancer","first-page":"4173","article-title":"A high frequency of BRCA mutations in young black women with breast cancer residing in Florida","volume":"121","author":"Pal T","year":"2015","unstructured":"Pal T, Bonner D, Cragun D,  A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer 2015;121:4173\u20134180."},{"key":"B37","series-title":"Clin Breast Cancer","first-page":"e220","article-title":"Health care disparities and demand for expanding hereditary breast cancer screening guidelines in African Americans","volume":"21","author":"Ciuro J","year":"2021","unstructured":"Ciuro J, Beyer A, Fritzler J,  Health care disparities and demand for expanding hereditary breast cancer screening guidelines in African Americans. Clin Breast Cancer 2021;21:e220\u2013227."},{"key":"B38","series-title":"Breast Cancer Res Treat","first-page":"591","article-title":"A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas","volume":"125","author":"Donenberg T","year":"2011","unstructured":"Donenberg T, Lunn J, Curling D,  A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat 2011;125:591\u2013596."},{"key":"B39","series-title":"Breast Cancer Res Treat","first-page":"131","article-title":"A survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago","volume":"159","author":"Donenberg T","year":"2016","unstructured":"Donenberg T, Ahmed H, Royer R,  A survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Breast Cancer Res Treat 2016;159:131\u2013138."},{"key":"B40","series-title":"J Clin Oncol","first-page":"2820","article-title":"Inherited breast cancer in Nigerian women","volume":"36","author":"Zheng Y","year":"2018","unstructured":"Zheng Y, Walsh T, Gulsuner S,  Inherited breast cancer in Nigerian women. J Clin Oncol 2018;36:2820\u20132825."},{"key":"B41","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"359","article-title":"Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon","volume":"29","author":"Adedokun B","year":"2020","unstructured":"Adedokun B, Zheng Y, Ndom P,  Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon. Cancer Epidemiol Biomarkers Prev 2020;29:359\u2013367."},{"key":"B42","series-title":"JAMA Oncol","first-page":"1045","article-title":"Comparison of the prevalence of pathogenic variants in cancer susceptibility genes in Black women and Non-Hispanic White women with breast cancer in the United States","volume":"7","author":"Domchek SM","year":"2021","unstructured":"Domchek SM, Yao S, Chen F,  Comparison of the prevalence of pathogenic variants in cancer susceptibility genes in Black women and Non-Hispanic White women with breast cancer in the United States. JAMA Oncol 2021;7:1045\u20131050."},{"key":"B43","series-title":"Genet Med","first-page":"601","article-title":"Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank","volume":"24","author":"Wang L","year":"2022","unstructured":"Wang L, Desai H, Verma SS,  Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank. Genet Med 2022;24:601\u2013609."},{"key":"B44","series-title":"Genet Med","first-page":"549","article-title":"Diversity in cancer genomics research is a matter of equity and scientific discovery","volume":"24","author":"Pal T","year":"2022","unstructured":"Pal T. Diversity in cancer genomics research is a matter of equity and scientific discovery. Genet Med 2022;24:549\u2013551."},{"key":"B45","series-title":"JCO Precis Oncol","first-page":"e2200084.","article-title":"Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition","volume":"6","author":"Hughes E","year":"2022","unstructured":"Hughes E, Wagner S, Pruss D,  Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition. JCO Precis Oncol 2022;6:e2200084."},{"key":"B46","series-title":"Genet Med","first-page":"101128.","article-title":"Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors","volume":"26","author":"Mabey B","year":"2024","unstructured":"Mabey B, Hughes E, Kucera M,  Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors. Genet Med 2024;26:101128."},{"key":"B47","series-title":"PLoS Med","first-page":"e1002644.","article-title":"Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: a nested case\u2013control study","volume":"15","author":"Zhang X","year":"2018","unstructured":"Zhang X, Rice M, Tworoger SS,  Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: a nested case\u2013control study. PLoS Med 2018;15:e1002644."},{"key":"B48","series-title":"J Natl Cancer Inst","article-title":"Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial","volume":"109","author":"Shieh Y","year":"2017","unstructured":"Shieh Y, Eklund M, Madlensky L,  Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Natl Cancer Inst 2017;109."},{"key":"B49","series-title":"Breast Cancer Res","first-page":"2.","article-title":"Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women","volume":"26","author":"Zirpoli GR","year":"2024","unstructured":"Zirpoli GR, Pfeiffer RM, Bertrand KA,  Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Res 2024;26:2."},{"key":"B50","series-title":"J Clin Oncol","first-page":"2564","article-title":"Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score","volume":"39","author":"Gao C","year":"2021","unstructured":"Gao C, Polley EC, Hart SN,  Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score. J Clin Oncol 2021;39:2564\u20132573."},{"key":"B51","series-title":"JAMA Netw Open","first-page":"e208501.","article-title":"Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes","volume":"3","author":"Gallagher S","year":"2020","unstructured":"Gallagher S, Hughes E, Wagner S,  Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes. JAMA Netw Open 2020;3:e208501."},{"key":"B52","series-title":"JAMA Oncol","first-page":"1066","article-title":"Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer","volume":"4","author":"Kurian AW","year":"2018","unstructured":"Kurian AW, Ward KC, Hamilton AS,  Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer. JAMA Oncol 2018;4:1066\u20131072."},{"key":"B53","series-title":"J Am Coll Radiol","first-page":"408","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo DL","year":"2018","unstructured":"Monticciolo DL, Newell MS, Moy L,  Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 2018;15:408\u2013414."},{"key":"B54","article-title":"Position statement on screening mammography","unstructured":"The American Society of Breast Surgeons. Position statement on screening mammography. Accessed May 13, 2021. Available at: https:\/\/www.breastsurgeons.org\/docs\/statements\/Position-Statement-on-Screening-Mammography.pdf"},{"key":"B55","series-title":"J Health Care Poor Underserved","first-page":"34","article-title":"Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research","volume":"23","author":"Anderson EE","year":"2012","unstructured":"Anderson EE, Hoskins K. Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research. J Health Care Poor Underserved 2012;23(Suppl 4): 34\u201346."},{"key":"B56","series-title":"J R Soc Med","first-page":"510","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris ZS","year":"2011","unstructured":"Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011;104:510\u2013520."},{"key":"B57","series-title":"JAMA","first-page":"403","article-title":"Practice-based research\u2013\u201cBlue Highways\u201d on the NIH roadmap","volume":"297","author":"Westfall JM","year":"2007","unstructured":"Westfall JM, Mold J, Fagnan L. Practice-based research\u2013\u201cBlue Highways\u201d on the NIH roadmap. JAMA 2007;297:403\u2013406."},{"key":"B58","series-title":"Maturitas","first-page":"107949.","article-title":"Racial disparities in breast cancer risk factors and risk management","volume":"184","author":"Pederson HJ","year":"2024","unstructured":"Pederson HJ, Al-Hilli Z, Kurian AW. Racial disparities in breast cancer risk factors and risk management. Maturitas 2024;184:107949."},{"key":"B59","series-title":"J Am Coll Radiol","first-page":"314","article-title":"Black women\u2019s perspectives on breast cancer risk assessment","volume":"20","author":"Spalluto LB","year":"2023","unstructured":"Spalluto LB, Bonnet K, Sonubi C,  Black women\u2019s perspectives on breast cancer risk assessment. J Am Coll Radiol 2023;20:314\u2013323."},{"key":"B60","series-title":"J Am Coll Radiol","first-page":"342","article-title":"Barriers to implementation of breast cancer risk assessment: the health care team perspective","volume":"20","author":"Spalluto LB","year":"2023","unstructured":"Spalluto LB, Bonnet K, Sonubi C,  Barriers to implementation of breast cancer risk assessment: the health care team perspective. J Am Coll Radiol 2023;20:342\u2013351."},{"key":"B61","series-title":"J Am Coll Radiol","first-page":"547","article-title":"Racial and ethnic disparities in radiology: a call to action","volume":"16","author":"Betancourt JR","year":"2019","unstructured":"Betancourt JR, Tan-McGrory A, Flores E, L\u00f3pez D. Racial and ethnic disparities in radiology: a call to action. J Am Coll Radiol 2019;16:547\u2013553."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/1\/article-e257079.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/1\/article-e257079.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/1\/article-e257079.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:58:06Z","timestamp":1767887886000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/1\/article-e257079.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":122,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2025.7079","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}